Literature DB >> 2838214

Abnormal scintigraphic evolution in AA hepatic amyloidosis.

F Lomeña1, R Roselló, F Pons, M Grau, A García, A Catafau, J Setoain.   

Abstract

A patient with AA amyloidosis secondary to ankylosing spondylitis showed intense liver uptake of Tc-99m MDP on bone imaging. The biopsy showed hepatic amyloid deposition. A repeat bone scan with Tc-99m MDP 1 year later was negative, although the clinical signs and liver function tests of the patient had not changed. A mechanism might exist, other than the affinity of amyloid to calcium, which would explain the extraosseous uptake of pyrophosphates and diphosphonates in organs and soft tissues affected by systemic amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838214     DOI: 10.1097/00003072-198803000-00015

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.

Authors:  Noboru Yamagata; Jyunko Fujio; Risen Hirai; Mutsumi Matsumaru; Satoshi Tanimura; Chiho Inokuchi; Tateki Shikai; Naoki Takezako; Michiyo Nasu; Yoichi Sakata; Naohiro Sata; Hideo Nagai; Ken Saito; Akiyoshi Miwa
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

2.  18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

Authors:  Akinobu Tawada; Tatsuo Kanda; Takashi Oide; Toshio Tsuyuguchi; Fumio Imazeki; Yukio Nakatani; Osamu Yokosuka
Journal:  Int Med Case Rep J       Date:  2014-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.